Project Grant R01DK146063
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $839,770 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support cognitive and behavioral approaches to reduce binge eating and excess weight in adolescents. The award is a Project Grant with a period of performance extending through February 28, 2031, and work is performed in New Haven, Connecticut. The program promotes extramural basic...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded Yale University $734,743 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate striatal dopamine responses to nutrient consumption and their relationship to food intake behavior and obesity. The research will measure brain dopamine dynamics in people with normal and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Leland Stanford Junior University $782,886 on February 18, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on obesity control through an appetite-suppressing peptide. The research addresses the urgent need for new metabolies, including obesity and associated metabolic disorders. Work is performed in Palo Alto, California with a period of...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health under the Department of Health and Human Services, awarded $717,030 to the University of Virginia on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to uncover neural circuits controlling body weight and metabolism. The research develops and applies RAMPANT (rabies afferent mapping by poly-A nuclear transcriptomics), a novel...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University $720,353 on March 25, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Assistance Listing Project Grant R01DK141555). The award funds research to identify and elucidate the functioning of hypothalamic neural circuits that regulate energy balance and metabolism, with focus on obesity-associated metabolic diseases. The research targets a...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of California, Berkeley $1.332 million on September 25, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate neuropeptidergic mechanisms underlying hedonic feeding behavior. The funded research examines neurotensin signaling in the pathway connecting the lateral nucleus accumbens to the ventral tegmental area, focusing on how this neuropeptide...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Duke University $637,471 under Project Grant R01DK143462 on April 1, 2026, to investigate the gut-brain signaling pathway by which the duodenum senses dietary lysine and regulates food intake behavior. The research will determine the intestinal signal transduction pathway for lysine detection and evaluate neuropod cell-dependent lysine-seeking behavior in lysine-depleted conditions. The work addresses the protein...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Duke University $790,119 on August 26, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate how memory formation in adipose tissue influences metabolic outcomes in obesity. The project, titled "Establishing Memory in Adipose Tissue Influences Future Metabolic Outcomes in Obesity," examines the mechanisms that drive divergent remodeling of white...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Southern California $845,922 on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate gut-brain pathways in childhood obesity and type 2 diabetes development. The research integrates neuroimaging, gut hormone measures, metabolic profiling, and lifestyle assessments in a longitudinal cohort of children ages 7 to 16 years, examining how...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $888,773 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK140210). The award funds research defining the contributions of hypothalamic microglia and perineuronal nets to obesity pathogenesis. The project investigates inflammatory activation of hypothalamic microglia in the arcuate nucleus and the loss of...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University a Project Grant of $861,091 on September 4, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The recipient will conduct neuroimaging and computational modeling research to identify the neural and decision-making mechanisms underlying loss-of-control eating and obesity. The research applies a novel framework positing that failures in self-control deployment depend primarily on individuals' estimates of the cognitive cost—difficulty or effort—associated with exercising control. The study combines functional MRI, computational modeling, and a self-control decision-making task to test the hypothesis that dysregulated eating and higher body mass indices are maintained by increased perceived cognitive costs of deploying control. The research sample includes adults with obesity who experience loss-of-control eating, defined as a sense of inability to stop eating or control quantity consumed. Performance occurs in New York, New York, with a period of performance from September 4, 2026, through June 30, 2031. The assistance type is a Project Grant, which funds basic and clinical biomedical research improving understanding of disease mechanisms and leading to improved prevention, diagnosis, and treatment across diabetes, digestive, endocrine, metabolic, nutrition, obesity, and related disease areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $861.1k | 9/3/26 |